207 207 ATC levelINNCommon nameATC codelinagliptin and empaglix0066006CozinD11AX22mifepristone combinationstrix0066006Curidine combinationsL04AC11x0066006Cuticasone furoateNew DDDs INN ID: 223133
Download Pdf The PPT/PDF document "ATC/DDD ClassicationATC/DDD ..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
207 207 ATC/DDD ClassicationATC/DDD Classication (Temporary)The following ATC codes and DDDs were agreed at the meeting of the WHO International Working Group for Drug Statistics Methodology in March 2014.Comments or objections to the decisions from the meeting should be forwarded to the WHO Collaborating Centre for Drug Statistics Methodology before 12014. If no objections are received before this date, the new ATC codes and DDDs will be considered nal and included in the January 2015 version of the ATC/DDD New ATC 5th level codes: ATC levelINN/Common nameATC codelinagliptin and empagliozinD11AX22mifepristone, combinationstriuridine, combinationsL04AC11uticasone furoateNew DDDs: INN/Common nameATC codeP (depot) Administration Route: O=oral; P=parenteral1) ATC code valid from January 2015 (current code L01XC04). WHO Drug Information Vol. 28, No. 2, 2014 208 ATC/DDD Classication (Final)The following ATC codes, DDDs and alterations were agreed at the meeting of the WHO International Working Group for Drug Statistics Methodology in October 2013. These are considered as nal and will be included in the January 2015 version of the ATC/DDD Index. The WHO Collaborating Centre for Drug Statistics Methodology can be contacted at whocc@fhi.no. The inclusion of a substance in the lists does not imply any recommendation for use in medicine or pharmacy.New ATC 5th level codes: ATC levelINN/Common nameATC codeatorvastatin and acetylsalicylic acidatorvastatin, acetylsalicylic acid and azilsartan medoxomil and diureticsazithromycin, uconazole and brinzolamide, combinationscefepime and amikacin cepeginterferon alfa-2bciprooxacin and metronidazole ciprooxacin and ornidazoleciprooxacin and tinidazole J01RA11coagulation factor Xcyclopentolate, combinationsS01FA54darunavir and cobicistatdonepezil, memantine and Ginkgo elosulfase alfaorbetaben ( 209 New ACT 5th level codes, continuedATC levelINN/Common nameATC codeformoterol and aclidinium bromide indometacin and antiinfectivesA03FA07lamivudine, abacavir and lamivudine and tenofovir disoproxil lansoprazole, amoxicillin and lansoprazole, clarithromycin and lansoprazole, combinationsmetformin and canagliozinmetronidazole, combinationsnebivolol and other hypertensivesnitrofurantoin, combinationsnoroxacin and tinidazoleooxacin and ornidazole palonosetron, combinationspeginterferon beta-1aperubutane polymer microspherespipenzolate and psycholepticsrabeprazole, combinationsrisedronic acid and colecalciferolrosuvastatin, amlodipine and rosuvastatin and amlodipinetetracycline and oleandomycin thiocolchicoside, combinationstiotropium bromide, combinations WHO Drug Information Vol. 28, No. 2, 2014ATC/DDD 210 New ACT 5th level codes, continuedATC levelINN/Common nameATC codeG04BE11umeclidinium bromideChange of ATC codes: INN/Common namePrevious ATC New ATCChange of ATC level names: ATC codeacetylsalicylic acid and acetylsalicylic acid, combinations Antihypertensives for pulmonary arterial hypertensioncefuroxime, combinations with other cefuroxime and metronidazole spiramycin, combinations with other spiramycin and metronidazole New DDDs: INN/Common nameATC codeB02BD11cepeginterferon alfa-2bdimethyl fumaratenalmefene Administration Route: O=oral; P=parenteral WHO Drug Information Vol. 28, No. 2, 2014 ATC/DDD Classication (Final)